- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00329979
Femoral vs Radial Approach and MRI Evaluation of Strokes
Silent Cerebral Infarction After Heart Catheterization: A Randomized Comparison of Radial and Femoral Arterial Access.
Symptomatic cerebral infarction following cardiac catheterization is rare but silent brain injury could occur at an unexpectedly high rate. One study has found that up to 22% of patients with severe aortic stenosis who have undergone retrograde catheterization of the valve can be identified as having new ischemic lesions as detected by diffusion-weighted (DW) magnetic resonance imaging (MRI). During cardiac catheterization, cerebral microembolism as detected by TCD has frequently been observed, but whether it is clinically relevant remains unknown . However, recent studies have suggested that some of these microemboli could be responsible for acute brain injury, as documented by DW MRI.
Indeed the high sensitivity of DW MRI suggests that this technique could allow an improved estimate of cerebral ischemic events associated with cardiovascular-catheter procedures. We therefore decided to perform DW MRI before and after cardiac catheterization to prospectively assess both clinically silent and apparent cerebral embolisms for the first time in a multicenter trial. Furthermore, a randomization between radial and femoral access will allow assessment of risk of silent brain injury associated with the different vascular access sites.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Caen, France, 14033
- CHU Caen, cardiology department
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient with significant aortic valve stenosis before planned surgery.
Exclusion Criteria:
- Contraindication to MRI or inability to give written informed consent.
Study Plan
How is the study designed?
Design Details
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
1
Radial access
|
Randomized vascular access site
|
|
2
Femoral access
|
Randomized vascular access site
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Michèle Hamon, MD, CHU Caen
- Principal Investigator: Martial Hamon, MD, CHU Caen
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2006-18
- no additional IDs
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Stenosis
-
National Institute of Cardiology, Warsaw, PolandThe Institute of Bioorganic Chemistry, Polish Academy of SciencesRecruitingAortic Stenosis | Low-gradient Aortic StenosisPoland
-
MiRusRecruitingAortic Stenosis | Symptomatic Severe Native Aortic StenosisUnited States
-
Anteris Technologies Ltd.Active, not recruitingAortic Stenosis | Aortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisUnited States
-
Edwards LifesciencesCompletedAortic Stenosis | Aortic Regurgitation | Symptomatic Aortic StenosisChina
-
Azienda Ospedaliera "Sant'Andrea"University of Bologna; Politecnico di Milano; Centro Cardiologico Monzino; I.R.C...RecruitingAortic Stenosis | Calcific Aortic Valve Disease | Chronic Coronary Syndrome | Calcific Aortic StenosisItaly
-
Hospices Civils de LyonCompleted
-
Edwards LifesciencesRecruitingAortic Valve Stenosis | Aortic Stenosis, CalcificUnited States, Australia, Switzerland, Canada, Japan, Netherlands
-
Abbott Medical DevicesCompletedSevere Aortic Stenosis | Symptomatic Degenerative Aortic StenosisSpain, Italy, United Kingdom, Germany, Switzerland, Czechia, Australia, Belgium, Poland
-
University of AlbertaNot yet recruitingAortic Stenosis | Severe Aortic StenosisCanada
-
Medtronic CardiovascularCompleted
Clinical Trials on vascular access site
-
Cordis CorporationEnsure MedicalCompletedCoronary Arteriosclerosis | Angioplasty, Transluminal, Percutaneous CoronaryMexico
-
Acibadem UniversityCompleted
-
C. R. BardTerminatedVascular Access ComplicationUnited States
-
Maastricht University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedHemodialysis Access Failure | Dialysis Access Malfunction | Vascular Access Malfunction | Hemodialysis Fistula ThrombosisNetherlands
-
Vascutek Ltd.Terminated
-
Wake Forest University Health SciencesWithdrawnPatient Satisfaction | Patient Preference
-
Federal University of São PauloCompletedPeripheral Vascular Disease | Cardiovascular InfectionsBrazil
-
Charles University, Czech RepublicUniversity Hospital Pilsen; University Hospital Hradec Kralove; Na Homolce Hospital and other collaboratorsCompletedST Elevation Myocardial InfarctionCzech Republic
-
Vidacare CorporationCompletedVascular AccessUnited States
-
Medtronic Neurovascular Clinical AffairsCompletedAcute Ischemic StrokeUnited States